Form D · Pharmaceuticals
IRONWOOD PHARMACEUTICALS INC
Cambridge, MA · CIK 0001446847
Offering snapshot reported Oct 11, 2016 · SEC filing
- Reported sold
- $150M Offering amount: $150M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 23, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 11, 2016 | Initial | $150,000,000 | No comparison | 2 | SEC filing |
| Jan 10, 2013 | Initial | $175,000,000 | No comparison | 18 | SEC filing |
| Nov 17, 2009 | Initial | $15,000,018 | No comparison | 1 | SEC filing |
| Sep 3, 2009 | Amendment | $249,996 | $0vs Aug 31, 2009 | 1 | SEC filing |
| Sep 3, 2009 | Initial | $24,999,996 | No comparison | 1 | SEC filing |
| Aug 31, 2009 | Initial | $249,996 | No comparison | 1 | SEC filing |
| Sep 26, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $20K
- Finders' fees
- $20K
- Form D file number
- 021-272208
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| J. WOOD CAPITAL ADVISORS | 169097 |
Source: Form D, filed Oct 11, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George H. Conrades | Director |
| Joseph C. Cook, Jr. | Director |
| Mark G. Currie | Executive |
| Andrew Dreyfus | Director |
| David A. Ebersman | Director |
| Marsha H. Fanucci | Director |
| Halley E. Giblert | Executive |
| Thomas Graney | Executive |
| Peter M. Hecht | Director, Executive |
| Michael J. Higgins | Executive |
| Stephen Knight | Director |
| Thomas A. Mccourt | Executive |
| Terrance G. Mcguire | Director |
| Julie H. Mchugh | Director |
| Gina Bornino Miller | Director |
| Lawrence S. Olanoff | Director |
| Edward P. Owens | Director |
| Bryan E. Roberts | Director |
| David E. Shaw | Director |
| Christopher T. Walsh | Director |
| Douglas E. Williams | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
301 Binney Street
Cambridge, MA, 02142
Cambridge, MA, 02142